Epoetin alfa

Izvor: Wikipedija
Prijeđi na navigaciju Prijeđi na pretragu
Epoetin alfa
Klinički podaci
Robne marke Epogen, Epogen (Amgen Inc.), Epogin (Chugai), Epomax (Elanex)
AHFS/Drugs.com alfa.html Monografija
Identifikatori
CAS broj 113427-24-0
ATC kod B03XA02 , B03XA01
DrugBank DB00016
ChEMBL[1] CHEMBL1201565 DaY
Hemijski podaci
Formula C815H1317N233O241S5 
Mol. masa 18396.1
Fizički podaci
Tačka topljenja 53 °C (127 °F)
Farmakoinformacioni podaci
Trudnoća ?
Pravni status
Način primene Subkutano, intravenozno

Epoetin alfa (rINN) rekombinantni je ljudski eritropoietin, koji se proizvodi u CHO ćelijama.[2][3][4]

Reference[uredi | uredi kod]

  1. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  2. Walsh G, Spada S (2005). „Epogen/Procrit”. Directory of approved biopharmaceutical products. Boca Raton: CRC Press. str. 39–41. ISBN 0-415-26368-9. 
  3. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.  edit
  4. David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.  edit

Literatura[uredi | uredi kod]

Spoljašnje veze[uredi | uredi kod]